KKRC
ABBV icon

Kohlberg Kravis Roberts & Co’s AbbVie ABBV Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-106,000
Closed -$6.68M – 55
2016
Q3 		$6.68M Buy
+106,000
New +$6.86M 0.08% 33

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Kohlberg Kravis Roberts & Co's ABBV Position: Q4 2016 in Review

Kohlberg Kravis Roberts & Co sold out of AbbVie (ABBV) in Q4 2016, closing a stake of 106,000 shares — an estimated $6.68M sold.

Kohlberg Kravis Roberts & Co first reported a position in ABBV in Q3 2016 and held it in 1 quarter. The position peaked at $6.68M in Q3 2016. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • Kohlberg Kravis Roberts & Co reported no remaining AbbVie position as of Q4 2016 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 106,000 AbbVie shares in Q4 2016, an estimated $6.68M.
  • Kohlberg Kravis Roberts & Co first reported a position in AbbVie in Q3 2016 and held it in 1 quarter.
  • Kohlberg Kravis Roberts & Co's AbbVie position peaked at $6.68M in Q3 2016.
  • 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q4 2016, filed 14 Feb 2017.